Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hollow-Fiber Bioreactors Market CAGR Outlook And Future Development
The hollow-fiber bioreactors market size has seen substantial growth in recent years. It is anticipated to expand from $1.5 billion in 2025 to $1.64 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. The market’s past growth can be attributed to factors such as reliance on traditional cell culture systems, limitations in bioreactor scalability, increasing biopharmaceutical research and development activities, a rise in academic research focused on tissue engineering, and the adoption of reusable bioreactors for early-stage production.
The hollow-fiber bioreactors market size is anticipated to expand considerably in the coming years. This market is projected to reach $2.33 billion by the year 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. During the forecast period, this increase can be linked to improvements in single-use bioreactor technologies, the growth of modular and automated systems, a growing need for high-throughput protein production, more outsourcing to contract research organizations (CROs), and the integration of continuous perfusion and monitoring systems. Significant trends expected in the forecast period include the growing acceptance of single-use hollow-fiber bioreactors, an expansion in high-density cell culture applications, an escalating requirement for biopharmaceutical protein production, the growth of tissue engineering and regenerative medicine, and a focus on automated and high-throughput bioreactor systems.
Get A Free Sample Report With In-Depth Market Insights:
Hollow-Fiber Bioreactors Market Growth Catalysts And Demand Drivers
The hollow-fiber bioreactors market is projected to expand due to the increasing need for cell-based therapy production. This type of production involves creating therapeutic items from living cells to address conditions like cancers, autoimmune issues, and genetic disorders. The rising demand for these therapies stems from the necessity for consistent, scalable manufacturing systems capable of handling high cell concentrations without compromising quality. Hollow-fiber bioreactors facilitate this by providing a high-surface-area, enclosed system that allows for the effective expansion and collection of therapeutic cells under regulated environments. For example, as reported in December 2024 by the International Federation of Pharmaceutical Manufacturers and Associations, a non-profit organization based in Switzerland, there were six first-in-class cell and gene treatments launched in 2023, marking a 50% increase from the three introduced in 2022. Consequently, the escalating demand for cell-based therapy production is boosting the hollow-fiber bioreactors market. The expanding adoption of personalized medicine is anticipated to drive growth within the hollow-fiber bioreactors market. Personalized medicine is a medical strategy that customizes treatments and healthcare choices to suit each patient’s unique attributes, requirements, and genetic makeup. This surge in personalized medicine is attributed to the growing use of sophisticated diagnostic tools that accurately pinpoint disease mechanisms specific to individual patients, allowing healthcare professionals to enhance treatment efficacy and minimize guesswork in therapy selection. Hollow-fiber bioreactors are crucial for personalized medicine, as they enable the scalable, high-quality production of cell cultures, which is essential for developing patient-specific therapies. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care entity, reported that the Food and Drug Administration (FDA), a US-based federal agency, cleared 16 new personalized therapies for patients with rare diseases in 2023, an increase from six in 2022. Thus, the rising prevalence of personalized medicine is stimulating the expansion of the hollow-fiber bioreactors market.
Hollow-Fiber Bioreactors Market Segment Landscape: Which Areas Lead Development?
The hollow-fiber bioreactors market covered in this report is segmented –
1) By Product Type: Single-Use Hollow-Fiber Bioreactors, Reusable Hollow-Fiber Bioreactors
2) By Application: Cell Culture, Tissue Engineering, Biopharmaceutical Production, Wastewater Treatment, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Contract Research Organizations, Other End-Users
Subsegments:
1) By Single-Use Hollow-Fiber Bioreactors: Pre-Assembled Single-Use Hollow-Fiber Bioreactors, Modular Single-Use Hollow-Fiber Bioreactors, Customizable Single-Use Hollow-Fiber Bioreactors, High-Throughput Single-Use Hollow-Fiber Bioreactors, Automated Single-Use Hollow-Fiber Bioreactors
2) By Reusable Hollow-Fiber Bioreactors: Fixed-Bed Reusable Hollow-Fiber Bioreactors, Modular Reusable Hollow-Fiber Bioreactors, High-Capacity Reusable Hollow-Fiber Bioreactors, Multipurpose Reusable Hollow-Fiber Bioreactors, Clean-In-Place Reusable Hollow-Fiber Bioreactors
Hollow-Fiber Bioreactors Market Trends Shaping Long-Term Demand
Major companies in the hollow-fiber bioreactors market are focusing on developing innovative solutions, such as single-use hollow-fiber membrane networks, to enable high-density, scalable, and low-shear cell culture suitable for advanced therapies. These single-use hollow-fiber membrane networks are disposable bioreactor systems, made of semi-permeable fibers, that facilitate continuous nutrient delivery and waste removal. This mechanism helps maintain uniform nutrient distribution, low-shear conditions, and scalable high-density cell growth, while simultaneously reducing contamination risk and simplifying biomanufacturing. For instance, in March 2025, ABEC Inc., a US-based process‑engineering company, launched its ATB (Advanced Therapy Bioreactor), a single-use, closed, hollow-fiber bioreactor platform specifically designed for advanced therapy medicinal product (ATMP) manufacturing. The ATB system incorporates proprietary hollow-fiber membrane networks that mimic the human circulatory system for localized nutrient and gas exchange, combined with oscillation-based mixing instead of mechanical agitation, to maintain optimal growth environments. Its design supports consistent scale‑up from 0.2 L to 10 L, preserving the same hollow-fiber surface-area-to-volume ratio across scales, and has demonstrated high densities and viabilities for a range of difficult-to-culture cells, including primary T-cells, CD34+ stem cells, HEK293, and CHO lines.
Hollow-Fiber Bioreactors Market Industry Leaders And Competitive Landscape
Major companies operating in the hollow-fiber bioreactors market are General Electric Company, Veolia Environnement S.A., Thermo Fisher Scientific Inc., Mitsubishi Chemical Corporation, Kubota Corporation, DuPont de Nemours Inc., MANN+HUMMEL GmbH, Alfa Laval AB, Sartorius AG, Repligen Corporation, Shenzhen Dreamemway Environmental Products Co. Ltd., FiberCell Systems Inc., Reynolds Culligan Water, Shanghai MegaVision Membrane Engineering & Technology Co. Ltd., Memfill Tech Private Limited, FibraCast Inc., iMemFlo Membrane Technology Co. Ltd., Guangdong Skyview Environmental Science and Technology Co. Ltd., PHILOS Co. Ltd., Blufox Engineering Pvt. Ltd.
View The Full Hollow-Fiber Bioreactors Market Report:
Hollow-Fiber Bioreactors Market Regional Analysis And Leading Geography
North America was the largest region in the hollow-fiber bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hollow-fiber bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
